Rock Springs Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Rock Springs Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-150,000	Closed	-$9.63M	–	133
2019 Q4	$9.63M	Buy	+150,000	New	+$8.59M	0.3%	87
2019 Q3	–	Sell	-1,050,000	Closed	-$47.6M	–	142
2019 Q2	$47.6M	Buy	+1,050,000	New	+$48.9M	1.72%	12
2018 Q2	–	Sell	-650,000	Closed	-$41.1M	–	148
2018 Q1	$41.1M	Buy	650,000 +600,000	+1,200%	+$38.6M	1.75%	10
2017 Q4	$3.06M	Hold	50,000	–	–	0.14%	124
2017 Q3	$3.19M	Hold	50,000	–	–	0.15%	117
2017 Q2	$2.79M	Sell	50,000 -402,600	-89%	-$21.9M	0.14%	116
2017 Q1	$24.6M	Buy	452,600 +2,600	+0.6%	+$143K	1.42%	23
2016 Q4	$26.3M	Buy	450,000 +200,000	+80%	+$10.9M	1.76%	17
2016 Q3	$13.5M	Buy	250,000 +53,500	+27%	+$3.44M	0.85%	38
2016 Q2	$14.5M	Buy	196,500 +26,500	+16%	+$1.87M	1.07%	28
2016 Q1	$10.9M	Buy	+170,000	New	+$10.7M	0.91%	33
2014 Q2	–	Sell	-185,500	Closed	-$9.64M	–	79
2014 Q1	$9.64M	Buy	185,500 +5,000	+3%	+$266K	2.22%	15
2013 Q4	$9.59M	Buy	+180,500	New	+$9.19M	3.43%	8

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rock Springs Capital Management's BMY Position: Q1 2020 in Review

Rock Springs Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 150,000 shares — an estimated $9.63M sold.

Rock Springs Capital Management first reported a position in BMY in Q4 2013 and held it in 13 quarters. The position peaked at $47.6M in Q2 2019. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Rock Springs Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
Rock Springs Capital Management sold 150,000 Bristol-Myers Squibb shares in Q1 2020, an estimated $9.63M.
Rock Springs Capital Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 13 quarters.
Rock Springs Capital Management's Bristol-Myers Squibb position peaked at $47.6M in Q2 2019.
2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Rock Springs Capital Management's 13F filing for Q1 2020, filed 15 May 2020.